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Abstract: Staphylococcus aureus is a major pathogen causing osteomyelitis, amongst other diseases, and
its methicillin-resistant form (MRSA) in particular poses a huge threat to public health. To increase our
knowledge of the origin and evolution of S. aureus, genetic studies of historical microorganisms may
be beneficial. Thus, the aim of this study was to investigate whether osteomyelitic skeletal material
(autopsy specimens collected from the mid 19th century until the 1920s) is suitable for detecting
historical S. aureus DNA sequences. We established a PCR-based analysis system targeting two
specific genes of S. aureus (nuc and fib). We successfully amplified the historical S. aureus nuc and fib
sequences for six and seven pre-antibiotic, osteomyelitic bone specimens, respectively. These results
encourage further investigations of historical S. aureus genomes that may increase our understanding
of pathogen evolution in relation to anthropogenically introduced antibiotics.
Keywords: Staphylococcus aureus; osteomyelitis; ancient DNA; pathological bone collection;
skeletal material; historical pathogens; infectious diseases; PCR; pre-antibiotic era
1. Introduction
Staphylococcus aureus is a major pathogen for both humans and animals, causing a variety
of diseases ranging from minor skin and soft tissue infection to severe, life-threatening medical
conditions like bacteraemia, endocarditis and toxic shock syndrome. Of all diseases caused by
S. aureus, only osteomyelitis enters the archaeological record. The clinical picture is characterized
by an increased irregular osteolytic destruction of the bone surface, the production of pus, and the
formation of woven bone, which is deposited on the periosteal surface, thus enlarging the affected
skeletal element. Although osteomyelitis is an unspecific clinical picture that can be caused by
several agents, S. aureus is the most frequently isolated causative organism in diagnosed osteomyelitis
cases [1]. S. aureus is the causative organism in 90% of the cases of modern diagnosed osteomyelitis
infection (e.g., [2]); historical references indicate that this pathogen played a major role in historical
osteomyelitis infections as well (e.g., [3]). Roberts and Manchester [4] assumed that primarily initiated
infection of the throat, ear, or the chest resulted in bacteremia and that the pyogenic bacteria reached
organs and bones via the bloodstream. Skinner and Keefer [5] estimated that, in pre-antibiotic
times, the mortality rate due to bacteremia initiated by S. aureus exceeded 80%. The discovery of
penicillin in 1928 by Sir Alexander Fleming [6] and its introduction into medical use in 1938 [7] laid
the primary foundation for improving health care. However, only a few years later, the first penicillin
resistant S. aureus strains were recognized [8]. These isolated strains acquired blaZ horizontally
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encoding ß-lactamase, which made them resistant to all β-lactamase susceptible penicillins. After the
introduction of β-lactamase unsusceptible agent methicillin into medical use, approximately 20 years
later, strains which were resistant against all known β-lactam agents (methicillin-resistant S. aureus
MRSA) were described (e.g., [9–11]) and subsequently spread through hospitals and care facilities
(reviewed in [12]). Since S. aureus became an increasing threat to human health, in the nineties, national
(Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. [13]) and international (European Antimicrobial
Resistance Surveillance Network [14]) organisations started to monitor MRSA rates. Evaluating data
from these organisations, after constantly increasing MRSA rates up until the beginning of the
twenty-first century, the improvement in hygienic standards led to a decreasing trend over the last
decade in Germany. Nevertheless, S. aureus still poses a huge threat to public health, as there are
large differences in the frequency of MRSA-rates both between various German hospitals and across
European countries.
To increase our knowledge about the origin and evolution of MRSA, Deurenberg and
Stobberingh [15] recommended focusing on historical S. aureus strain collections. Several studies
have shown that genes encoding resistances to multiple modern antibiotics are not only a result
of the treatment with clinical antibiotics but can be found in genomes of ancient bacteria [16,17].
Those bacteria were found in different remote places never before in contact with human activities
(e.g., caves and permafrost). Their genomic make-up is interpreted to prove the existence of a natural
resistome [18,19] beyond modern human pharmaceutical influence [16,17]. If such a characteristic
were to be proven in historical S. aureus this may be seen in the context of the emergence and
persistence of MRSA-strains. Further, studies of microorganisms from ancient remains can also help
us understand host–pathogen interactions in the context of the emergence of infectious diseases [20].
Generally, comparing the genetic profiles of modern bacterial isolates with those of historical
strains increases our understanding of the transmission and spread of infectious diseases and the
corresponding pathogens [21].
The invention of the polymerase chain reaction (PCR) three decades ago enabled ancient DNA
(aDNA) studies. Only a short time later, the first paleomicrobiological applications were presented
by Salo et al. [22], who reported the successful extraction and amplification of specific Mycobacterium
tuberculosis sequences from the soft tissue of a 1000-year-old Peruvian mummy. Spigelman and
Lemma [23] first extracted and amplified M. tuberculosis DNA from skeletal material using the PCR
technique, which was later successfully applied to pathological and archaeological skeletal material
(e.g., [24–26]). Furthermore, evidence of other infectious diseases and their causative pathogens, like
Mycobacterium leprae (e.g., [27–29]), Yersina pestis (e.g., [30,31]), and Bartonella quintana (e.g., [32,33])
from archaeological material was provided.
To the best of our knowledge, there is no report of a successful DNA extraction and amplification
of historical S. aureus DNA sequences from human remains. Thus, the aim of this study was to
investigate whether the osteomyelitic skeletal material assembled in the pathological collection of the
Department of Historical Anthropology and Human Ecology is suitable for detecting the presence
of analysable S. aureus DNA sequences. Positive results would encourage further investigation of
historical, pre-antibiotic S. aureus sequences to improve our understanding of the molecular events
that led to the origin and rise of resistance to anthropogenically introduced antibiotics.
2. Materials and Methods
2.1. Materials
2.1.1. Osteomyelitic Bone Specimens
Bone specimens from seven different adult individuals (represented by few bones each) with
apparent signs of an osteomyelitis infestation were chosen from the pathological collection of the
Department of Historical Anthropology and Human Ecology (Figure 1). This large collection was
assembled from autopsy specimens from the mid 19th century until the 1920s. The bones used in
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this study were permanently stored in the collections’ magazine, and have thus not been handled
intensively over the last decades. Each bone was sampled at the diaphysis and four of the specimens
were sampled additionally at a position close to the metaphysis that revealed morphologically
detectable signs of osteomyelitis (Figure 1 arrows). Hence, eleven samples were investigated to
prove the presence of S. aureus DNA sequences. Unlike archaeological skeletal material, the bone
specimens of the pathological collection have never been in contact with soil-inhabiting bacteria, which
can colonize skeletal material [34]. Nevertheless, the PCR system should be designed in a way that
it is applicable to archaeological material, which has usually been buried. To test the PCR system in
the presence of DNA from soil-inhabiting bacteria as well as PCR inhibitors like humic acids, which
are present in every type of soil [35], several spiking experiments were performed (Supplementary
Text S1).
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2.2.1. DNA Extraction
In order to remove possible cellular contamination from the sample surfaces, they were exposed
to 6% sodium hypochlorite solution (Aug. Hedinger GmbH & Co. KG, Stuttgart, Germany)
(e.g., [37,38]). Lysis and DNA extraction was performed according to a protocol as described by
Frischalowski et al. [39]. For decalcification and lyses, 0.25 mg bone powder was incubated with
3900 µL EDTA (0.5 M, pH 8.0, Invitrogen™, Carlsbad, CA, USA) and 100 µL proteinase K solution
in Tris/HCl (pH 7.5, 0.01 mol/L, 600 mAnson-U/mL, Merck, Darmstadt, Germany) for 18 h at 37 ◦C
under constant rotation. An additional 50 µL proteinase K was added and a second lyses step, again
under constant rotation, was performed for another 2 h at 56 ◦C. Afterwards, a 10 min incubation with
50 µL sodium dodecyl sulphate (10 mg/mL, Sigma-Aldrich®, St. Louis, MO, USA) was performed at
65 ◦C. After a 3 min centrifugation at 3300 rcf (Type 5430R, Eppendorf, Hamburg; Germany), the entire
lysate of approximately 4100 µL was used for phenol-chloroform extraction. For this purpose, the entire
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lysate was transferred to 3 mL phenol (Carl Roth GmbH + Co. KG, Karlsruhe, Germany) and manually
inverted for 6 min at room temperature. For phase separation, the extracts were incubated at 56 ◦C
for 10 min. As much as possible of the aqueous phase was transferred to 4.5 mL chloroform (Carl
Roth GmbH + Co. KG, Karlsruhe, Germany). Again, the samples were manually inverted for 6 min
at room temperature and afterwards incubated at 56 ◦C for 10 min. The aqueous phase was then
transferred to a mixture of 16 mL PB-Buffer (Qiagen, Hilden, Germany) and 100 µL sodium acetate
buffer (pH = 5.2, 3 M Sigma-Aldrich®, St. Louis, MO, USA). The mixture was transferred to MinElute™
spin columns (Qiagen, Hilden, Germany) and DNA purification was performed via the QIAvac-System
(Qiagen, Hilden, Germany) following the manufacturer’s protocol. The elution of the DNA from the
MinElute™ spin columns (Qiagen, Hilden, Germany) was performed by using 20 µL RNAse free water
(Qiagen, Hilden, Germany). After 5 min of incubation, centrifugation was performed at 13,000 rpm for
1 min. Elution was repeated twice to a total elution volume of 60 µL. The DNA extracts were stored
frozen at −20 ◦C. For samples of the diaphysis at least two independent DNA extracts were prepared,
for the samples close to the metaphysis one DNA extract each (Supplementary Text Table S1).
2.2.2. Primer Design
Ancient DNA analyses are highly dependent on optimal analysis conditions. This holds
particularly true for the historical bone specimens investigated in this study, since they are expected
to contain only traces of pathogenic DNA along with comparatively large quantities of human
and microbial DNA, in case of the pathological collection due to maceration and taphonomic
processes. Amplification sensitivity and specificity are mainly determined by primer characteristics [40].
Hence, the prerequisites for optimized primers—appropriate energy profile, avoidance of hairpins
and primer dimer formation, and matching melting temperatures—were met. For the primer design
for the amplification of specific sequences of the genes nuc [41] and fib [42] of S. aureus, the software
PrimerSelect™ (DNASTAR, Madison, WI, USA) and the reference sequence of strain NCTC8325
(accession CP000253.1, cf. material-Staphylococcus aureus genomic DNA) was used. Primer specificity
to the S. aureus complex was subsequently confirmed by BLASTN 2.2.32+ analysis [43,44] (Table 1).
A cross reaction particularly with other Staphylococcus species (e.g., Staphylococcus epidermidis, common
on the skin of humans) can be excluded.
Table 1. Primer sequences for the S. aureus loci 1.
Position Name PrimerLength Sequence






Forward S.aur nuc up 2 26-mer 5’-GGCAATTGTTTCAATATTACTTATAG-3’ 800069 . . . 800094 122 bp
Reverse S.aur nuc low 28-mer 5’-TTGAAACTACAACTAAAGTTAACACTAA-3’ 800163 . . . 800190
Forward S.aur fib up 20-mer 5’-GAAGGATACGGTCCAAGAGA-3’ 1073163 . . . 1073128 111 bp
Reverse S.aur fib low 23-mer 5’-AGGTGTTGAGTTAAATTTTGGTC-3’ 1073251 . . . 1073273
1 Using the amplification parameters described in this paper for both the nuc and the fib system, as little as
10 genomes/targets can be amplified and analysed by gel electrophoresis (data not shown). 2 The “T” at the
sequence position seven of S.aur nuc up indicates a polymorphism (“C” instead of a “T”) at the primer binding site
of S. aureus strain NCTC 8325 (positive control).
2.2.3. Amplification of S. aureus DNA
The amplification reactions each consisted of a total volume of 25 µL with one part AmpliTaq
Gold®360 Master Mix (Applied Biosystems®, Waltham, MA, USA), 0.4 µM of each primer (forward
and reverse), and a DNA inset varying between 0.5 and 6 µL (the DNA amount in the extracts varied
because of the differential state of sample preservation). PCR conditions were as follows: initial phase
at 94 ◦C for 7 min, 40 cycling steps consisting of 94 ◦C for 1 min, 46 ◦C for 1 min (nuc) or 50 ◦C (fib),
and 72 ◦C for 1 min, and soak for 10 min at 10 ◦C.
Amplification of the X region of the protein A gene (spa typing) (e.g., [45,46]) and sequence analysis
was done by the Robert Koch Institute as described by Strommenger et al. [47] (Supplementary Text S6).
Diversity 2017, 9, 43 5 of 15
The amplified PCR products were separated by gel electrophoresis. Run time was approximately
30 min at 120 V in a 2.5% gel in 1xTBE buffer.
2.2.4. Sequence Analysis of PCR Products
Sequencing of the purified amplification products (Supplementary Text S3) was carried out in
a direct taq cycle sequencing approach with a total reaction volume of 20 µL. Each reaction mix
consisted of one part BigDyev1.1 5X Sequencing Buffer (Applied Biosystems®, Waltham, MA, USA),
one part BigDye®Terminator v1.1 Ready Reaction Mix (Applied Biosystems®, Waltham, MA, USA),
0.24 µM primer (forward or reverse), and a PCR product inset varying between 0.5 and 5 µL. The PCR
cycling conditions were as follows: initial phase at 96 ◦C for 10 min, 25 cycling steps consisting of 96 ◦C
for 10 s, 50 ◦C for 5 s, and 60 ◦C for 4 min, and a final soak at 10 ◦C. Analysis of the purified sequencing
products (Supplementary Text S3) was conducted via 3500 Genetic Analyzer (Applied Biosystem®,
Waltham, MA, USA) and data processing was applied by using SeqA (Applied Biosystem®, Waltham,
MA, USA) and the DNASTAR Lasergene 10 Core Suite software package (DNASTAR, Madison, WI,
USA). The specificity of all amplified sequences was confirmed by BLASTN 2.2.32+ analysis [43,44].
2.2.5. Contamination Prevention
Concerning contamination, all aDNA analyses were conducted following a rigorous cleaning
protocol and established laboratory standards that minimalize the contamination risk (e.g., [40,48].
All laboratory surfaces, instruments and bone samples underwent a strict cleaning protocol with 6%
sodium hypochlorite solution (Aug. Hedinger GmbH & Co. KG, Stuttgart, Germany).
In order to easily detect possible external contamination with either human or even pathogenic
DNA, there were three general strategies: (i) All DNA extracts of the bone specimens were checked for
foreign human DNA via short tandem repeat typing (STR typing). Since STR typing only identifies
human DNA and does not exclude a possible contamination with pathogenic DNA through a processor.
(ii) The processors were screened for S. aureus colonization via culture of nasal swabs (Supplementary
Text S4). In the case that none of the processors was a carrier of S. aureus, a late introduction of a modern
contamination through a processor (e.g., contamination of a single tube during the PCR-setup) could
be excluded. In the case that one of the processors had been a carrier of S. aureus, sequence analysis
of the cultures would have been carried out allowing a differentiation e.g., through single nucleotide
polymorphisms or spa typing. (iii) Several control samples and extraction blank controls were amplified
with the S. aureus primer sets and the corresponding amplification parameters (Supplementary Text S1)
to screen for possible S. aureus contaminants in extraction and PCR reagents.
The positive control sample of S. aureus was stored and handled separately from the historical
DNA extracts during all steps in a working station (UV-bench DNA/RNA UV-Cleaner, UVT-S-AR)
in a separate room and was always prepared last. Those precautions were taken to avoid
a cross-contamination between the positive control sample (S. aureus strain NCTC8325) and the
DNA extracts of the historical bone specimens.
2.2.6. STR Typing
STR typing was conducted with a miniSTR system [49] which was designed particularly for
aDNA applications. Every DNA extract was tested twice, before and after amplifications were carried
out for S. aureus analysis. The allele determination was performed by capillary electrophoresis via
3500 Series Genetic Analyzer (Applied Biosystems®, Waltham, MA, USA) and data processing was
applied with the GeneMapper5 (Applied Biosystems®, Waltham, MA, USA) software (Supplementary
Text S5).
Diversity 2017, 9, 43 6 of 15
3. Results
3.1. Amplification of Staphylococcus aureus Sequences from Osteomyelitic Bone Specimens
This study successfully conducted analyses of historical S. aureus sequences. The extraction
revealed variable amounts of both human and pathogenic DNA from the different samples as judged
by the differential brightness of amplification product in the respective gel pictures. The 122 bp
fragments of the nuc gene was reproducibly amplified for eight out of eleven samples (Figure 2,
Supplementary Figure S1, Table 2). The band intensity of most of the amplification products compared
to that of the positive control indicates that there were less than 100 targets in the respective PCR.
In contrast, the gel bands of 13:K:40:7 are much brighter than that of the positive control, indicating by
far more than 100 targets in the reaction. The 111 bp fib fragment was amplified for ten out of eleven
samples (Supplementary Figure S2, Table 2).
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Figure 2. Results of the PCR-based detection of S. aureus specific 122 bp nuc sequences after agarose
gel electrophoresis (DNA inset bracketed). Gel bands are located between the 100 bp and 150 bp
fragments of the DNA ladder, indicating that the sought amplification product of 122 bp was generated.
9/14 amplifications resulted in visible bands; the negative template control (NTC) shows no evidence of
pathogenic DNA presence in the PCR reaction mix. As a positive control, DNA of the strain NCTC8325
(approximately 100 genomes) was used. Electrophoresis parameters: 8 µL PCR product with 2 µL
loading dye, 4 µL size standard: 50 bp DNA ladder (Invitrogen™, Carlsbad, CA, USA), 2.5% gel, 120 V,
exposure time: 1.00 s. For detailed description of the extract nomenclature see Supplementary Text
Table S1.
Concerning spa typing, only the sample 13:K:40:7 revealed an amplification product with
a fragment length between 350 and 500 bp (Supplementary Text S6) visualized by gel electrophoresis.
The spa type of this sample was determined as “t017” (Ridom StaphType, Ridom GmbH, [50]).
Clustering analysis via the Based Upon Repeat Pattern algorithm [47] revealed an affiliation to the
clonal complex “CC30”.
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Table 2. Overall amplification success of S. aureus sequences visualized by gel electrophoresis (Figure 2,
Supplementary Figures S1 and S2).




13:K:40:7 diaphysis + +











+ = specific amplification product; − = no amplification product.
3.2. Sequencing of Staphylococcus aureus Sequences from Osteomyelitic Bone Specimens
For each bone sample revealing a positive signal in one of the PCR attempts for either the
nuc (eight samples, Supplementary Figure S3) or fib locus (ten samples, Supplementary Figure S4),
forward and reverse sequencing was performed. A BLASTN 2.2.32+ search [43,44] of the amplified
historical sequences revealed sequence similarities to the reference sequences of the positive control
sample NCTC 8325 between 97% and 99% for nuc and between 99% and 100% for fib, respectively.
The alignment of the amplified historical nuc sequences and the genome of strain NCTC 8325
showed several polymorphisms (Figure 3). All amplified historical sequences reveal three single-base
polymorphisms (C42T, A113T, and T129C) deviating from the reference sequences of the positive
control sample NCTC 8325. Positions 89 to 90 revealed a polymorphic region where either
double adenine or double guanine is present. For two amplified sequences (13:K:42:12_Ex3 and
13:K:42:14_Ex7), a double purine base (R = A or G) was determined. The alignment of the amplified fib
sequences revealed only three base deviations in two historical samples (Supplementary Figure S5).
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Figure 3. Alignment of the consensus nuc sequence of the historical bone specimens (primer binding
sequence was removed) and the nuc gene of the S. au ference strain NCTC 8325 (CP000253.1,
positive control sample). Base differing from the ref uc sequence are framed. Software:
MegAlign™ (DNAST R, Madison, WI, USA). For the ali t of all amplified forward (fwd.) and
reverse (rev.) sequences and the corresponding electropherograms see Supplementary Figures S3
and S6.
With the nuc sequencing results a phylogenetic analysis was performed. A comparison of the two
nuc sequence variants obtained from the historical samples (13:K:40:4 Ex6 and 13:K:40:7 Ex2) with
publically available sequences of S. aureus belonging to different clonal complexes was conducted.
Furthermore, the sequences of Staphylococcus schweitzeri [51] and Staphylococcus argenteus [52,53] were
used as an outgroup, as they both also belong to the S. aureus complex. Multiple alignments were
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performed using MegAlign™ (DNASTAR, Madison, WI, USA) and the phylogenetic relationship
was visualized (Figure 4). As can be deduced from the phylogenetic tree, the 68 bp sequence
variant as realised in 13:K:40:7_Ex2 clusters with the S. aureus strain MRSA 252 [54] and CA-347 [55].
The respective sequence characteristics of the 13:K:40:4_Ex6 cluster with the S. aureus isolates Mu3 [56],
MW2 [57], RF122 [58], 08-02300 [59], JH9 [60], HO 5096 0412 [61], 08-02119 [59], N315 [62], Mu 50 [62],
and MSSA476 [54].
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Figure 4. Phylogenetic relations based on the alignment (Figure S7 in supplementary data) of two
historical nuc sequence variants of 13:K:40:4 Ex6 and 13:K:40:7 Ex2 and nuc sequences of seventeen
contemporary S. aureus strains. S. schweitzeri and S. argenteus were used as the out group. Software:
MegAlign™ (DNASTAR, Madison, WI, USA), Method: Jotun Hein.
3.3. STR Typing
Human STR typing of the historical DNA sa pl s i i t t at there were considerable
differences in DNA preservation amongst the investigated bone speci ens. When working with
aDNA STR typing those differences may include variability in a plification success, allelic drop-out,
preferential amplification of smaller STR systems (at the expense of the larger systems), or artefacts as
a consequence of overamplified stutter products (e.g., [40,63,64]). The specimens 13:K:40:4, 13:K:40:7,
and 13:K:42:3 revealed excellent DNA preservation resulting in full genetic fingerprints, whereas the
remaining bone specimens (13:K:40:9, 13:K:42:12, 13:K:42:14, and 13:K:43:1) showed a poorer state of
DNA preservation resulting in only a limited number of alleles (Supplementary Text Tables S4–S10).
4. Discussion
This study succeeded in finding specific DNA of S. aureus in seven investigated specimens from
a pathological bone collection from historical times. Therefore, it is most likely that S. aureus was
the causative organism of the morphologically manifested osteomyelitis infection. We succeeded in
amplifying S. aureus-specific sequences of the two genes nuc and fib.
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The investigation demonstrated that, as expected for aDNA analyses, different amounts of both
pathogenic and human DNA were extracted from the pathological bone specimens. Due to the nature
of DNA degradation, e.g., DNA fragmentation, human and pathogenic DNA were not quantified.
We rather conducted initial spiking experiments with different amounts of S. aureus reference DNA
demonstrating that approximately 10 to 50 genome equivalents are sufficient for a light band to be
visible in the agarose gel picture (data not shown). Similar band intensities could be observed during
the investigation of the DNA extracts of the pathological bone specimens, indicating that at least
approximately 10–50 intact targets ought to be present in most of the historical extracts. Extracts of
the bone specimen 13:K:40:7 were always amplified with a decreased DNA inset and yet revealed
a brighter amplification product in gel electrophoresis (Figure 2, Supplementary Figures S1 and S2).
The comparison of the band intensities of the spiking experiments with those of 13:K:40:7 revealed
that by far higher amounts of pathogenic DNA was extracted and amplified from this sample (data
not shown).
The evaluation of all amplified historical nuc sequences showed various polymorphisms
differing from the nuc sequence of the strain NCTC 8325 (Figure 3). Hence, signals for historical
S. aureus sequences are not a result of a contamination from the positive control. When analysing
aDNA, contaminations should always be considered as a possible cause of positive signals during
investigations. In this context, a processor in contact with the samples or the positive control is
usually suspected of being the origin of a contamination. However, the spatial separation of the
positive control from the historical samples makes a cross-contamination between them very unlikely.
Furthermore, concerning S. aureus contamination through one of the processors (Flux, A.L. and
Mazanec, J.), screening for S. aureus via a cultivation of swabs from the nasal mucosa on blood
agar plates (Institute for Medical Microbiology, University Medical Center Goettingen) detected no
colonization of the processors by the bacteria. In case of a contamination with DNA from one of the
processors or from another bone specimen the detection of multiple allels in the STR typing results
would have been expected. However, the comparison of the subsequent fingerprints showed that
a contamination could be excluded (Supplementary Text Tables S4–S11). Therefore, it can be assumed
that the results are authentic and not a result of a modern contamination.
Sequence variations of the nuc gene of 13:K:42:12, 13:K:42:14, and 13:K:40:4 were observed, within
different samples (metaphysis and diaphysis) of the corresponding bone specimen, possibly indicating
the presence of different S. aureus strains. Historically, S. aureus carriage as well as infection has
been assumed to be monoclonal [65]. However, recent research data has indicated that polyclonal
colonization is more common than previously anticipated [66,67]. During the investigation of the
pathological samples sequencing of two different DNA extracts from one specimen (13:K:40:4, Figure 3)
revealed different sequence characteristics, both being reproduced by forward and reverse sequencing
reactions. This may be an indication that two different S. aureus strains colonized the individual in its
lifetime. Specimen 13:K:42:12 also revealed two different sequence characteristics in two investigated
extracts. It should be noted, however, that the sample 13:K:42:12 Ex3 revealed different characteristics
in the forward and reverse amplified sequence that may be explained as a PCR artefact through e.g.,
base misincorporation. This assumption is strongly supported by the unusually high number of
amplification cycles of the sample (in total, 70 cycling steps), because it was necessary to reamplify
the PCR product before the sequencing reaction (Supplementary Text S3). The sequence of the
sample 13:K:42:14 Ex7 revealed sequence characteristics similar to the sequences of sample 13:K:42:12
Ex3, but it was not reamplified before direct sequencing. The differences between the forward and
reverse amplified sequences occurred repeatedly, making it difficult to evaluate whether the sequence
characteristics can also be explained as a PCR artefact or as two sequences of different S. aureus strains
being amplified.
Concerning spa typing, the amplification failure of the spa locus for the entire historical samples,
except for 13:K.40:7, was not surprising since the spa amplicon size (approx. > 200 base pairs) is
comparatively long with respect to aDNA analysis. Additionally, the primers for the spa locus
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were designed for the amplification of contemporarily isolated S. aureus DNA and do not meet
aDNA requirements (Section 2.2.2). However, the spa type of 13:K.40:7 was determined as “t017”
clustering to the clonal complex “CC30” (Section 3.1). Clonal complex 30 (CC30) had been involved
in different pandemic “waves” and was also part of the toxic shock syndrome epidemic. It includes
the historic phage-type 80/81 strains and contemporary community, as well as hospital associated
MRSA (CA-/HA-MRSA). Related methicillin-susceptible S. aureus (MSSA) are common human nasal
colonizers worldwide [68].
Phylogenetic analysis shows different clustering for both sequence variants obtained from the
historical samples (13:K:40:4 Ex6 and 13:K:40:7 Ex2) to the reference sequences of the S. aureus complex.
Sequence 13:K:40:7 Ex2 clusters with MRSA252, which is in concordance with the determined spa type
and clonal complex (CC30). The other historical sequence (13:K:40:4 Ex6) clusters in a group with
S. aureus sequences belonging to various clonal complexes. This is not surprising, since there were
no sequence variations within the amplified nuc sequences. Since the analysis was carried out with
only 68 bp, further genome-wide analysis will be necessary to assess a robust phylogenetic relation
between the historical sequences and those of contemporary S. aureus strains.
To the best of our knowledge, recent investigations focussing on analysing the genome of
historical pathogens with PCR- or NGS-based methods were limited to archaeological skeletal material
(e.g., [69–77]) or non-archaeological preserved soft tissues (e.g., [78–80]). The first successful
investigation on non-archaeological, macerated bones assembled in the pathological collection was
performed by Baron et al. [24]; we have now demonstrated yet again that these bone samples are
suitable for extracting analysable amounts of both human and pathogenic DNA. In addition to
archaeological material, these pathological samples are especially beneficial for the investigation of
pathogens causing diseases limited to only single individuals in a skeletal series and not those leading
to epidemics and mass burials in the archaeological context. Hence, these findings encourage further
investigation of sample material from pathological collections and might establish a new approach to
historical genomes of not only S. aureus but other pathogens causing the clinical picture of osteomyelitis,
as well as other diseases. In the case of S. aureus, genome analysis of strains colonizing patients before
the introduction of penicillin into medical use may increase our understanding of host–pathogen
interactions and pathogen evolution in relation to anthropogenically introduced antibiotics.
Supplementary Materials: The following are available online at www.mdpi.com/1424-2818/9/4/43/s1.
Flux et al. 2017 Supplementary Text Figure S1. Results of the PCR-based detection of the S. aureus specific
nuc sequence; Figure S2. Results of the PCR-based detection of the S. aureus specific fib sequence; Figure S3.
Electropherograms of all amplified historical nuc sequences; Figure S4. Electropherograms of all amplified
historical fib sequences, Figure S5. Alignment of forward and reverse fib sequences of the historical bone
specimens; Figure S6. Alignment of forward and reverse nuc sequences of the historical bone specimens;
Figure S7. Alignment of two historical nuc sequences and reference sequences.
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